Category: Biosimilars
Biosimilars market research reports by BlueWeave Consulting
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
Asia Pacific Next Generation Antibody Market Size More Than Doubles to Surpass USD 2.06 Billion by 2030 Asia Pacific Next generation Antibody Market is propelled by the increasing prevalence of chronic diseases, rising investments in antibody research and development programs, advancements in biotec ... Read More
-
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
North America Human Insulin Drugs Market - By Product (Human Insulin, Basal Insulin, Bolus Insulin, Insulin Combinations, Biosimilar Insulins); By Application (Product I Diabetes, Product II Diabetes); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 No ... Read More
-
United States Human Insulin Market, By Product Type (Human Insulin Drugs, Human Insulin Delivery Devices); By Type (Insulin Analogs and Biosimilars, Human Insulin Biologics); By Delivery Devices (Syringes, Pens, Pen Needles); By Application (Type I Diabetes, Type II Diabetes); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
United States Human Insulin Market, By Product Type (Human Insulin Drugs, Human Insulin Delivery Devices); By Type (Insulin Analogs and Biosimilars, Human Insulin Biologics); By Delivery Devices (Syringes, Pens, Pen Needles); By Application (Type I Diabetes, Type II Diabetes); By Distribution Channe ... Read More
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, a ... Read More
-
India Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
India Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, an ... Read More
Research Assistance
